4.6 Article

A Within-Subject Comparison of 6-[18F]Fluoro-m-tyrosine and 6-[18F]Fluoro-L-dopa in Parkinson's Disease

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Overeating Behavior and Striatal Dopamine with 6-[F-18]-Fluoro-L-m-Tyrosine PET

Claire E. Wilcox et al.

JOURNAL OF OBESITY (2010)

Article Clinical Neurology

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

C. W. Christine et al.

NEUROLOGY (2009)

Review Neurosciences

Relationship of Striatal Dopamine Synthesis Capacity to Age and Cognition

Meredith N. Braskie et al.

JOURNAL OF NEUROSCIENCE (2008)

Article Clinical Neurology

Results from a phase I safety trial of hAADC gene therapy for Parkinson disease

J. L. Eberling et al.

NEUROLOGY (2008)

Article Biotechnology & Applied Microbiology

Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC

Krystof S. Bankiewicz et al.

MOLECULAR THERAPY (2006)

Article Clinical Neurology

Contribution of aging to the severity of different motor signs in Parkinson disease

G Levy et al.

ARCHIVES OF NEUROLOGY (2005)

Article Clinical Neurology

Tolcapone - A review of its use in the management of Parkinson's disease

GM Keating et al.

CNS DRUGS (2005)

Article Chemistry, Medicinal

Positron-labeled DOPA analogs to image dopamine terminals

OT DeJesus

DRUG DEVELOPMENT RESEARCH (2003)

Article Endocrinology & Metabolism

Increase in dopamine turnover occurs early in Parkinson's disease:: Evidence from a new modeling approach to PET 18F-fluorodopa data

V Sossi et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)

Article Clinical Neurology

Rate of progression in Parkinson's disease:: A 6-[18F]fluoro-L-dopa PET study

E Nurmi et al.

MOVEMENT DISORDERS (2001)

Article Endocrinology & Metabolism

A reversible tracer analysis approach to the study of effective dopamine turnover

V Sossi et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)